“To hear European stem-cell researchers talk last week, you might have thought that their world was ending. After the European Court of Justice ruled on 18 October that procedures involving human embryonic stem (ES) cells cannot be patented, many responded with shock and dismay …” (more)
[Ewen Callaway, Nature News, 24 October]